Skip to main content

Table 2 Overview of instruments per time of assessment

From: Efficacy of a hybrid online training for panic symptoms and agoraphobia: study protocol for a randomized controlled trial

Assessments Screening T0 T1 T2 T3
Sociodemographic data x - - - -
Suicidality (Item 9, BDI-II) x - - - -
Diagnosis (SCID-I, sections for anxiety disorders and current depressive episode) - x - -  
Panic and agoraphobia severity, self-rating (PAS) x x x x x
Panic and agoraphobia severity, observer-rating (HAM-A) - x x - -
Agoraphobic cognitions (ACQ) - x x x x
Body sensations (BSQ) - x x x x
Agoraphobic avoidance (MI) - x x x x
Depressive symptoms (CES-D) - x x x x
Quality of life (EQ-5D, SF-12) - x x x x
Economic evaluations (TiC-P) - x - - x
Negative effects of online health trainings - - (x) (x) (x)
Attitudes towards seeking psychological help - - (x) - -
User satisfactory - - (x) - -
Technology acceptance of smartphone app - - (x) - -
Usability of smartphone app (SUS) - - (x) - -
  1. T0 = Baseline, T1 = 8 weeks, T2 = 3 months, T4 = 6 months.
  2. Assessments: x = intervention and control group, (x) = intervention group only.
  3. ACQ, Agoraphobic cognitions questionnaire; BDI-II, Beck Depression Inventory II; BSQ, Body sensations questionnaire; CES-D, Center for epidemiological studies depression scale; EQ-5D, EuroQol; HAM-A, Hamilton anxiety scale; MI, Mobility inventory; PAS, Panic and agoraphobia scale; SCID-I, Structured clinical interview for DSM-IV Axis I Disorders; SF-12, Short form 12; SUS, System Usability Scale; TiC-P, Trimbos and the Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry.